SpyGlass Pharma, Inc. Common Stock (SGP) ownership: Top institutional holder: RA CAPITAL MANAGEMENT, L.P. ($207.83M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 8021117.00 | $207.83M | 2026-03-31 |
| NEA Management Company, LLC | 7392301.00 | $191.53M | 2026-03-31 |
| Sands Capital Alternatives, LLC | 2500012.00 | $64.78M | 2026-03-31 |
| COMERICA INC | 1571114.00 | $57.39M | 2001-03-31 |
| SAMSARA BIOCAPITAL, LLC | 2109953.00 | $54.67M | 2026-03-31 |
| Vestal Point Capital, LP | 666760.00 | $17.28M | 2026-03-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 550000.00 | $14.25M | 2026-03-31 |
| JPMORGAN CHASE & CO | 577109.00 | $13.49M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-02-09 | |
| Sell | null | 2026-02-09 | |
| Sell | null | 2026-02-09 | |
| Sell | null | 2026-02-09 | |
| Sell | null | 2026-02-09 | |
| Sell | null | 2026-02-09 | |
| Sell | null | 2026-02-09 | |
| Sell | null | 2026-02-09 |
Back to SGP overview · SGP earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.